Study on How Mini-Gastric Bypass Surgery Affects Comorbidities and Body Composition in Adults with Morbid Obesity

What this Trial Is About

This observational study focuses on people with morbid obesity undergoing mini-gastric bypass MGB surgery. Researchers want to understand how improvements in obesity-related health problems, such as type II diabetes, sleep apnea, hypertension, and hypothyroidism, relate to changes in body composition after surgery. The study also looks at metabolic syndrome parameters, cardiovascular risk markers, and complications from surgery over time. Participants will have mini-gastric bypass surgery following standard medical procedures, with no additional experimental treatments. The study observes patients with morbid obesity and related conditions like type 2 diabetes, hypertension, dyslipidemia, sleep apnea, hypothyroidism, and chronic venous hypertension. The surgery aims to help control these comorbidities. During the three-year follow-up, researchers will monitor changes in body composition and health markers after surgery. They will track metabolic syndrome parameters, cardiovascular biomarkers, and any surgical complications requiring intervention, extended hospital stays, or extra outpatient visits. This long-term observation helps understand the relationship between surgery outcomes and health improvements in morbidly obese patients.

Comorbidities Resolution After MGB Surgery and Change in Body Composition